News Releases
Metacrine to Present at Jefferies 2019 London Healthcare Conference
SAN DIEGO, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Ken Song, M.D., President and CEO, will present at the
Nov 18, 2019
Metacrine to Present at H.C. Wainwright 2019 NASH Investor Conference
SAN DIEGO, October 15, 2019  – Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Hubert Chen, M.D., Chief Medical Officer, will present at the H.C.
Oct 15, 2019
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, today announced that Ken Song, M.D., President and CEO, will present at the
May 21, 2019
Displaying 11 - 20 of 36